The Chinese stock market resisted the lethargy seen across the Asia-Pacific region today, standing out with notable gains (CHN.cash: approx. +1.4%). Optimism was driven by IPOs of two GPU companies focused on AI, sparking broad tech sector gains, particularly in Baidu shares (BIDU.US: +4.9% in after-hours trading).
Futures on the HSCEI index halted a three-day losing streak, resuming an attempt to break the current downtrend. The price approached the 23.6% Fibonacci retracement level and paused just below the 30-day exponential moving average (EMA30; light line). A trend reversal would likely require a break above the EMA100 resistance (dark purple). Source: xStation5
What is driving CHN.cash today?
-
GPU producer Biren Technology’s IPO was oversubscribed 2,363 times, highlighting continued investor appetite for AI-related stocks despite Western bubble concerns. Another semiconductor company, Iluvatar CoreX Semiconductor, also launched its IPO in Hong Kong, aiming to raise about $475 million.
-
Investor interest primarily supported Chinese tech giant Baidu, whose shares surged 8.9% during the Asian session, lifting it to the top of the HSCEI index. Bloomberg reports suggest such strong demand for these startups may prompt Baidu to accelerate the IPO of its own semiconductor arm.
-
The second-best performer on HSCEI was SMIC, which, despite general sector gains, signed an agreement with the Chinese government to increase its share capital from $6.5 billion to $10 billion, and plans to raise an additional $547 million through a new share issue.
Natural gas surges 4% amid US cold weather adn strong demand 📈What's next?
DE40: DAX hits a 2.5-month high 📈 Rheinmetall jumps on renewed Russia–Ukraine tensions
Silver jumps 3% as buyers step in after the crash 📈
Economic calendar: All eyes on FOMC minutes (30.12.2025)
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
